Medicare Enrolled
Dr. Mitul Kanzaria, MD
Cardiovascular Disease · Sunnyside, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kanzaria from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kanzaria?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kanzaria
Dr. Mitul Kanzaria is a cardiovascular disease specialist in Sunnyside, WA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kanzaria performed 2,111 Medicare services across 1,402 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kanzaria received a total of $13,249 from 45 pharmaceutical and/or device companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kanzaria is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 30% volume in WA
$13,249 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,111
Medicare services
Top 30% in WA for cardiovascular disease
1,402
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~132 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
469 | $100 | $774 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
319 | $67 | $487 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
274 | $99 | $827 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
190 | $12 | $98 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
142 | $138 | $1,231 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
108 | $11 | $342 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
59 | $178 | $2,485 |
| Cardiac catheterization | 57 | $183 | $1,807 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
47 | $154 | $1,313 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
41 | $75 | $588 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
37 | $431 | $3,671 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $112 | $1,086 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $146 | $1,181 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $108 | $853 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
31 | $19 | $171 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
24 | $159 | $1,317 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
23 | $2 | $85 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
22 | $18 | $133 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
22 | $12 | $88 |
| Additional heart vessel ultrasound evaluation An additional ultrasound assessment of a specific heart blood vessel or graft, including radiologist review. |
20 | $63 | $477 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
20 | $6 | $50 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $264 | $2,266 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
18 | $57 | $471 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
15 | $72 | $918 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
14 | $407 | $2,998 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
14 | $11 | $86 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
13 | $14 | $151 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
11 | $60 | $426 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.6% high complexity
11.4% medium
81.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,249
Total received (2018-2024)
Avg $1,893/year across 7 years
Top 12% in WA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
543
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,249 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,449
2023
$2,689
2022
$2,266
2021
$1,642
2020
$1,449
2019
$1,844
2018
$911
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$718
ABIOMED
$425
Abbott Laboratories
$231
Amgen Inc.
$187
AstraZeneca Pharmaceuticals LP
$151
Philips North America LLC
$142
Becton, Dickinson and Company
$78
Inari Medical, Inc.
$67
ShockWave Medical, Inc
$65
Novartis Pharmaceuticals Corporation
$51
PFIZER INC.
$50
iRhythm Technologies, Inc.
$44
CVRx, Inc.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$21
Lexicon Pharmaceuticals, Inc.
$19
Penumbra, Inc.
$18
ABBVIE INC.
$18
Novo Nordisk Inc
$17
LANTHEUS MEDICAL IMAGING, INC.
$16
Esperion Therapeutics, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 56.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$2,317
Abbott Laboratories
$1,497
ABIOMED
$1,491
AstraZeneca Pharmaceuticals LP
$1,117
Janssen Pharmaceuticals, Inc
$933
Medtronic, Inc.
$778
E.R. Squibb & Sons, L.L.C.
$679
Amgen Inc.
$521
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$409
Philips Electronics North America Corporation
$368
BOSTON SCIENTIFIC CORPORATION
$355
Boehringer Ingelheim Pharmaceuticals, Inc.
$335
PFIZER INC.
$254
Novartis Pharmaceuticals Corporation
$249
Merck Sharp & Dohme LLC
$161
Edwards Lifesciences Corporation
$157
Philips North America LLC
$142
Penumbra, Inc.
$134
Medtronic Vascular, Inc.
$125
iRhythm Technologies, Inc.
$121
ShockWave Medical, Inc
$109
Cardinal Health 200, LLC
$108
Inari Medical, Inc.
$103
W. L. Gore & Associates, Inc.
$85
Cardiovascular Systems Inc.
$81
Becton, Dickinson and Company
$78
SANOFI-AVENTIS U.S. LLC
$72
CeloNova BioSciences, Inc.
$68
ABBVIE INC.
$62
Lexicon Pharmaceuticals, Inc.
$62
CVRx, Inc.
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
United Therapeutics Corporation
$26
Lantheus Medical Imaging, Inc.
$20
Impulse Dynamics (USA) Inc.
$19
Novo Nordisk Inc
$17
Althera Pharmaceuticals LLC
$17
LANTHEUS MEDICAL IMAGING, INC.
$16
Esperion Therapeutics, Inc.
$15
CORDIS US CORP.
$15
Melinta Therapeutics, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$14
Kiniksa Pharmaceuticals, Ltd.
$13
Amarin Pharma Inc.
$13
CSL Behring
$11
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (6496) FM Other · (6571) Eagle Eye · (6575) Coronary Undivided · (6585) Omniwire · (7882) Image Guided Therapy Und · ANDEXXA · ASSURITY · AVEIR · AVVIGO · AVVIGO Guidance System · AVYCAZ · Allure CRT Pacemaker · AngioJet XMI · Arcalyst · BRILINTA · Barostim Neo System · Baxdela · CAMZYOS · CARDIOFORM Septal Occluder · CROSSBOSS · Comet · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DEFINITY · DRAGONFLY OPSTAR · Diamondback Peripheral · ELIQUIS · ENCORE · ENTRESTO · ESPRIT · EUPHORA · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EluNIR Radaforolimus Eluting Coronary Stent System · Emerge Push · Euphora · FARXIGA · FEMOSTOP · FFR Link · FLOWTRIEVER CATHETER · Fighter · FilterWire EZ · GALLANT · GENERAL METALLIC STENTS · GENERAL THERAPIES · GENERAL - VASCULAR ACCESS · Guidezilla · Hornet 10 · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JETI ALL IN ONE NON-STERILE KIT · JOT DX · LATITUDE · LAUNCHER · LEQVIO · LINQ II · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MAMBA · MICRA · MULTAQ · Mailman · MitraClip System · MynxGrip Vascular Closure Device · NEXLETOL · ONYX FRONTIER · OPTIS · OptiCross · Optimizer · Optis Coronary Imaging System · PRESSUREWIRE · PROMUS · Penumbra System · PressureWire FFR · RAILWAYTM · RAIN SHEATH · RAIN SheathTM · RESOLUTE ONYX · ROTAPRO · Repatha · Resolute · Roszet · S · SAMSCA · SELECTSECURE · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEFLARO · TENDRIL · TYVASO · VERQUVO · VYNDAQEL · Vascepa · Venovo · WATCHMAN · WATCHMAN FLX · WOLVERINE · Wegovy · Wolverine Coronary Cutting Balloon · XARELTO · XIENCE SKYPOINT · XIFAXAN · Xience Sierra Coronary Stent System · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
6
Per 100K population
2.9
County median income
$87,316
Nearest hospital
ASTRIA SUNNYSIDE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kanzaria is a clinical cardiology specialist, with above-average Medicare volume (top 30% in WA), with low-engagement industry engagement in the top 12% of WA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kanzaria experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kanzaria performed 469 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kanzaria receive payments from pharmaceutical companies?
Yes. Dr. Kanzaria received a total of $13,249 from 45 companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kanzaria's costs compare to other cardiologists in Sunnyside?
Dr. Kanzaria's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kanzaria) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Sunnyside
Browse cardiologists in Sunnyside ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in WA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in WA
Which WA cardiologists receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology